// App-Quantinova.ai

TPS3098 : Phase I/II study of mogamulizumab, an anti-CCR4 antibody targeting regulatory t cells in advanced cancer patients.

Researchers

Presenter

  • George Plitas

Principal Investigators

  • Kenmin Wu

  • Jeremie Carlson

  • Nicholas Cimaglia

  • Monica Morrow

  • Alexander Y. Rudensky

  • Jedd D. Wolchok

Medical Centers

  • Memorial Sloan Kettering Cancer Center, Port Washington, NY

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Triple-negative breast cancer

  • Non Small Cell Lung cancer

  • Gastric Cancer

  • Small cell lung cancer

  • Breast cancer

  • Lung Cancer

  • Solid malignancies

Biomarkers

  • Regulatory T cells

Drug/Treatment

  • Mogamulizumab

Outcome

  • N/A

Study Design

  • Dose Escalation

Phase

  • I/II

Study Id's

  • NCT02281409

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved